PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Neurology, Cedars-Sinai Medical Center, Los Angeles, California, USA, maxpadrick@gmail.com.\', \'Kaiser Permanente, Los Angeles Medical Center, Los Angeles, California, USA.\', \'Department of Neurology, Cedars-Sinai Medical Center, Los Angeles, California, USA.\', \'Cedars-Sinai Medical Center, Biostatistics and Bioinformatics Research Center, Los Angeles, California, USA.\', \'Zilka Neurogenetic Institute at Keck School of Medicine of USC, Los Angeles, California, USA.\', \'Department of Neurology, University of California, Los Angeles, California, USA.\', \'Providence Saint John\'s Health Center, Santa Monica, California, USA.\', \'Providence Little Company of Mary Medical Center- Torrance, Torrance, California, USA.\', \'PIH Health Whittier Hospital, Whittier, California, USA.\', \'Department of Neurosurgery, University of Southern California, Los Angeles, California, USA.\', \'PIH Health Good Samaritan Hospital, Los Angeles, California, USA.\', \'Torrance Memorial Medical Center, Torrance, California, USA.\', \'Providence Saint Joseph Medical Center, Burbank, California, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1159/000516908
?:hasPublicationType
?:journal
  • Cerebrovascular diseases (Basel, Switzerland)
is ?:pmid of
?:pmid
?:pmid
  • 34175851
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • COVID-19 Impact on Acute Ischemic Stroke Treatment at 9 Comprehensive Stroke Centers across Los Angeles.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all